Table 2.
Summary of baseline characteristics of participants.
| Characteristics | All patients (N=139) | Control (n=44) | App (n=46) | App and physician (n=49) | |
| Age (years), mean (SD) | 53 (13) | 56 (15) | 50 (10) | 53 (12) | |
| Sex (female), n (%) | 139 (100) | 44 (100) | 46 (100) | 49 (100) | |
| Chemotherapy, n (%) | |||||
| Adjuvant | 86 (61.9) | 25 (57) | 30 (65) | 31 (63) | |
| Neoadjuvant | 50 (36) | 18 (41) | 16 (35) | 16 (33) | |
| Surgery, n (%) | |||||
| Biopsy (sentinel) | 50 (36) | 17 (39) | 16 (35) | 17 (35) | |
| Breast conserving | 72 (51.8) | 23 (52) | 27 (59) | 22 (45) | |
| Breast ablation | 14 (10.1) | 3 (7) | 3 (7) | 8 (16) | |
| Interval (days), median (IQR; range) | |||||
| Visits 1-2 | 21 (6; 6-43) | 21 (6; 6-43) | 20 (6; 7-27) | 21 (2; 7-42) | |
| Visits 2-3 | 21 (8; 6-42) | 21 (9; 7-42) | 21 (7; 7-28) | 20 (7; 6-28) | |
| Visits 1-3 | 42 (7; 13-84) | 42 (2; 14-84) | 41 (9; 26-49) | 39 (7; 13-56) | |